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Background: In the current study we aimed to ﬁnd out the impact of cytokine-inducible Src
homology 2 domain protein (CISH) gene polymorphisms on the risk of pulmonary tubercu-
losis  (PTB) in a sample of Iranian population.
Materials and methods: Polymorphisms of CISH rs2239751, rs414171, and rs6768300 were
determined in 200 PTB patients and 200 healthy subjects using T-ARMS-PCR or PCR-RFLP
method.
Results: The results showed that rs414171 A>T genotypes signiﬁcantly decreased the risk of
PTB (OR = 0.16, 95% CI = 0.10–0.27, p < 0.0001, AT vs AA; OR = 0.31, 95% CI = 0.14–0.68, p < 0.0001,
TT  vs AA; OR = 0.19, 95% CI = 0.12–0.29, p < 0.0001, AT+TT vs AA; OR = 0.29, 95%CI = 0.20–0.42,
p  < 0.0001, T vs A). For rs6768300, the ﬁndings indicated that this variant decreased the risk of
PTB  (OR = 0.52, 95% CI = 0.33–0.82, p = 0.005, CG vs GG; OR = 0.57, 95% CI = 0.38–0.87, p = 0.012,
C  vs G). No signiﬁcant association was observed between CISH rs2239751 polymorphism and
risk/protection of PTB.Conclusion: Our ﬁndings indicated that CISH rs414171 and rs6768300 variants might be asso-
ciated with protection from PTB.
© 2016 Elsevier Editora Ltda. This is an open access article under the CC BY-NC-ND
million women and 1.0 million children) new cases occurredntroduction
uberculosis (TB), an infectious disease, is the leading cause
f global morbidity and mortality mainly in Asia and Africa.1,2
oughly one-third of the world’s population is infected
ith TB; however, approximately 5–15% of those infected
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individuals will develop active TB during their lifetime,
typically within the ﬁrst 2–5 years after the initial infection.
It has been estimated that 9.6 million (5.4 million men, 3.2.ir (M. Hashemi).
in 2014 according to the global tuberculosis report from World
Health Organization (WHO).3 Though environmental and
social factors also contribute to susceptibility to TB, there is
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Fig. 1 – Photograph of tetra ampliﬁcation refractory
mutation system-polymerase chain reaction (T-ARMS-PCR)
for detection of CISH rs2239751 A>C polymorphism. Product
sizes were 180-bp for C allele, 251-bp for A allele, and
376-bp for control. M,  DNA Marker; Lanes 1 and 3, AA;380  b r a z j i n f e c t d 
considerable evidence that host genetic factors play a key role
in susceptibility to the disease.4–6 In humans, the cytokine-
inducible Src homology 2-containing protein is encoded by the
CISH gene, which is located on the short arm of chromosome
3 (3p21.3).7 It contains four exons, of which exons 2–4 encode
the CISH protein which is an important negative regulator
for inﬂammatory cytokine signaling.7,8 It has been proposed
that the interleukin-2 (IL-2)-mediated immune response is
essential for host defense against infectious pathogens and
CISH play a key role in controlling IL-2 signaling.9
Few studies have investigated the impact of CISH polymor-
phisms on TB and found an association between the variants
and the risk of TB.10–12 To the best of our knowledge, there
is no report regarding the possible association between CISH
gene polymorphisms and the risk of PTB in the Iranian popu-
lation. Thus, the present study aimed to examine the possible
associations between rs2239751, rs414171 and rs6768300 poly-
morphisms of CISH gene and susceptibility to PTB in a sample
of the Iranian population.
Materials  and  methods
Study  population
Two hundred patients diagnosed with PTB and 200 healthy
subjects were enrolled in this case-control study. The
study design and enrollment process have been described
previously.13,14 The cases were selected from PTB patients
admitted to a university-afﬁliated hospital (Bou-Ali Hospital,
Zahedan, referral center for TB). Brieﬂy, diagnosis of PTB was
based on clinical symptoms, radiological evidence, and bacte-
riological investigations such as sputum Acid Fast Bacilli (AFB)
smear positivity, culture, and response to anti-tuberculosis
chemotherapy. All control subjects were unrelated adults
selected through the population without signs, symptoms or
history of TB and from the same geographical origin, as the
patients with PTB.
The local ethics committee of the Zahedan University of
Medical Sciences approved the project, and informed consent
was obtained from all individual participants included in the
study. Genomic DNA was extracted from the whole blood by
the salting out method as described previously.15
Genotyping
In this study we  designed a tetra-primer ampliﬁcation
refractory mutation system polymerase chain reac-
tion (T-ARMS PCR) for detection of CISH rs2239751 and
rs414171polymorphism.
For rs2239751 we  used two external primers (FO:
GGGAAGACTACTTCTCCCTTGCTGTCT, RO: GCTGATGTG-
GTAGCTGGGTGTATGAATA) and two internal primers (FI (C
allele)): GAACAAAGTTTTAGACTGCTGCGCTCTAC, RI (A allele):
TTCTAGGTACATGTGTGTGCCCGTTT.
PCR was performed in 25 l reaction volumes containing
0.4 M of each primer, 250 M of each dNTP, 1 U Taq DNA poly-
merase with 1.5 mM MgCl2, and 50 ng genomic DNA. The PCR
cycling conditions was as follows: an initial denaturation step
of 5 min  at 95 ◦C followed by 30 cycles of 30 s at 95 ◦C, annealingLanes 2 and 4, AC.
at 62 ◦C for 30 s and extension at 72 ◦C for 30 s. Final exten-
sion was performed at 72 ◦C for 5 min. The PCR products were
separated by electrophoresis in 2% agarose gels, and observed
under ultraviolet light. Product sizes were C allele 180-bp, A
allele 251-bp, and control 376-bp, as shown in Fig. 1.
For rs414171 we used two  external primers FO: ACGC-
CGACAGACCTCCTTGGAGGAG, RO: GAAGCAGCGTCTTCCTA-
GAACCGCGG, and two internal primers FI (T allele):
TGCTATTGGCCCTCCCCGACCACT, RI (A allele): CGCGACGCT-
GAAGGTGGAGCTGT.
PCR was performed in 25 l reaction volumes containing
0.4 M of each primer, 250 M of each dNTP, 1 U Taq DNA poly-
merase with 1.5 mM MgCl2, and 50 ng genomic DNA.  The PCR
cycling conditions was as follows: an initial denaturation step
of 5 min  at 95 ◦C followed by 30 cycles of 30 s at 95 ◦C, annealing
at 68 ◦C for 30 s and extension at 72 ◦C for 30 s. Final exten-
sion was performed at 72 ◦C for 5 min. The PCR products were
separated by electrophoresis in 2% agarose gels, and observed
under ultraviolet light. Product sizes were A allele 290-bp, T
allele 208-bp and control 452-bp, as shown in Fig. 2.
Detection of CISH rs6768300 polymorphism was done by
PCR restriction fragment length polymorphism (PCR-RFLP)
method. The set of forward and reverse primers were: 5′-
GCGAGCTGCTGCCTAATC-3′ and 5′-GCTCGGCTCCACCTTCAG-
3′, respectively.
PCR was performed in 25 l reaction volumes containing
0.4 M of each primer, 250 M of each dNTP, 1 U Taq DNA poly-
merase with 1.5 mM MgCl2, and 50 ng genomic DNA.  The PCR
cycling conditions was as follows: an initial denaturation step
of 5 min  at 95 ◦C followed by 30 cycles of 30 s at 95 ◦C, annealing
at 58 ◦C for 30 s and extension at 72 ◦C for 30 s. Final extension
was performed at 72 ◦C for 5 min. PCR products were digested
with HhaI restriction enzyme.
The PCR products were separated by electrophoresis in 2%
agarose gels, and observed under ultraviolet light. G allele
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Fig. 2 – Photograph of tetra ampliﬁcation refractory
mutation system-polymerase chain reaction (T-ARMS-PCR)
for detection of CISH rs414171 A>T polymorphism. Product
sizes were  208-bp for T allele, 290-bp for A allele, and
452-bp for control. M,  DNA Marker; Lanes 1 and 4, AT; Lane
2
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undigested) 234-bp, while C allele digested and produces 101-
nd 133-bp (Fig. 3).
tatistical  analysisnalysis of the data was done using the SPSS 18.0 soft-
are.  The differences between the variables were evaluated by
hi-square test or independent sample t-test according to the
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ig. 3 – Electrophoresis pattern of the PCR-RFLP method for
etection of CISH rs6768300 C>G polymorphism. The G
llele undigested (234-bp), while C allele digested by HhaI
estriction enzyme and produces 101-bp and 133-bp. M,
NA marker; Lanes 1 and 3, CG; Lane 2, GG.6;2 0(4):379–383 381
data. The associations between genotypes and PTB were cal-
culated by computing the odds ratio (OR) and 95% conﬁdence
intervals (95% CI) from logistic regression analyses. p-Value
less than 0.05 was considered statistically signiﬁcant.
Results
The study consisted of 200 PTB (76 males, 124 females; ages
49.8 ± 20.4 years) patients and 200 healthy subjects (87 males
and 113 females; ages 49.2 ± 15.1 years). There was no signif-
icant difference between the groups concerning sex and age
(p = 0.309 and p = 0.707, respectively). Genotypes and allele fre-
quencies of CISH polymorphisms are shown in Table 1.
The results showed that rs414171 A>T genotypes signif-
icantly decreased the risk of PTB in codominant (OR  = 0.16,
95% CI = 0.10–0.27, p < 0.0001, AT vs AA; OR = 0.31, 95%
CI = 0.14–0.68, p < 0.0001, TT vs AA), and dominant (OR = 0.19,
95% CI = 0.12–0.29, p < 0.0001, AT+TT vs AA) inheritance model
tested. Furthermore, the T allele signiﬁcantly decreased the
risk of PTB (OR = 0.26, 95% CI = 0.18–0.38, p < 0.0001) com-
pared to A allele. For rs6768300, the ﬁndings showed that
this CG genotype decreased the risk of PTB (OR = 0.52, 95%
CI = 0.33–0.82, p = 0.005) in comparison with GG genotype. The
C allele signiﬁcantly decreased the risk of PTB (OR = 0.57, 95%
CI = 0.38–0.87, p = 0.012) compared to G allele. No statistically
signiﬁcant association was detected between CISH rs2239751
polymorphism and risk/protective of PTB.
We estimated the Hardy–Weinberg equilibrium (HWE) for
controls. In controls, the genotype distribution of rs414171
(2 = 0.982, p = 0.321), but not rs6768300 variant (2 = 7.52,
p = 0.006) was in HWE. The rs2239751 variant was not poly-
morphic in our population.
Discussion
In the present study we investigate the impact of CISH
rs2239751, rs414171, and rs6768300 polymorphisms on the
risk of PTB in a sample of the Iranian population. Our ﬁnd-
ings indicated an association between rs414171 and rs6768300
polymorphisms of CISH gene and risk of PTB. Regarding
rs414171, the AT and TT genotypes as well as T allele sig-
niﬁcantly decreased the risk of PTB. For rs6768300, the CG
genotype and G allele signiﬁcantly decreased the risk of PTB.
We found no signiﬁcant association between rs2239751 vari-
ant and PTB.
In a case-control study, Ji et al.10 found that presence of
either the T allele of rs414171 or the C allele of rs2239751
increased susceptibility to clinical TB in Chinese Han pop-
ulation. They found no signiﬁcant association between CISH
rs622502 variant and risk of TB.
Sun et al.12 investigated the impact of CISH gene pro-
moter polymorphisms (rs414171, rs622502 and rs80945) on TB
risk in Chinese children. They found that subjects carrying
the rs414171TT homozygotes and rs809451GC heterozygotes
had a 1.78-fold and 1.86-fold excess risk of developing TB
compared to those with wild-type genotypes. Their ﬁndings
proposed that CISH promoter rs414171 and rs809451 poly-
morphisms might play a vital role in mediating individual
susceptibility to TB. Zhao et al.11 have found that rs2239751
382  b r a z j i n f e c t d i s . 2 0 1 6;2  0(4):379–383
Table 1 – Genotypes and allele frequencies of CISH polymorphisms in pulmonary tuberculosis (PTB) and control group.
CISH polymorphism Case
n (%)
Control
n  (%)
OR  (95%CI) p
rs414171 A>T
Codominant
AA 160 (80.0) 86 (43.0) 1.00 –
AT 29 (14.5) 95 (47.5) 0.16 (0.10–0.27) <0.0001
TT 11 (5.5) 19 (9.5) 0.31 (0.14–0.68) <0.0001
Dominant
AA 160 (80.0) 86 (43.0) 1
AT+TT 40 (20.0) 114 (57.0) 0.19 (0.12–0.29) <0.0001
Recessive
AA+AT 189(94.5) 181(90.5) 1.00
TT 11 (5.5) 19 (9.5) 0.55 (0.26–1.20) 0.13
Allele
A 349 (87.2) 267(66.8) 1.00 –
T 51 (12.8) 133 (33.2) 0.29 (0.20–0.42) <0.0001
rs6768300 G>C
GG 160 (80.0) 135 (67.5) 1.00 –
CG 40 (20.0) 65 (32.5) 0.52 (0.33–0.82) 0.005
CC 0 (0.0) 0 (0.0) – –
Allele
G 360 (90.0) 335 (83.8) 1.00 –
C 40 (10.0) 65 (16.2) 0.57(0.38–0.87) 0.012
rs2239751 A>C
AA 196 (98.0) 200 (100.0) 1.00 –
AC 4 (2.0) 0 (0.0) – –
CC 0 (0.0) 0 (0.0) – –
Allele
400
0
rA 396 (99.0) 
C 4 (1.0) 
and rs414171variants in CISH gene increased the risk of TB in
Chinese Han population. They found no signiﬁcant associa-
tion between rs622502 and rs6768300 variants and TB risk.
Khor et al.9 investigated CISH polymorphisms at positions
−639 (rs148685070), −292 (rs414171), −163 (rs6768300), +1320
(rs2239751), and +3415 (rs622502). They showed an associ-
ation between CISH genetic variants and susceptibility to
bacteremia, malaria, and tuberculosis when they considered
all polymorphisms together in a multiple-SNP score.9
It has revealed that in humans the CISH gene is most con-
sistently up-regulated by interleukin-2 stimulation,16 and it
seems to be critical for T-cell proliferation and survival17 in
response to infection. CISH controls the signaling pathway
of a variety of cytokines, especially interleukin-2. CISH binds
to the phosphorylated tyrosine residues of cytokine receptors
and blocks the cytoplasmic docking and activation of signal
transducer and activator of transcription 5 (STAT5),8,18–21 so
inhibits downstream signal transduction.
One of the limitations of the present study is the rela-
tively small sample size. There is no clear description for the
deviation from HWE  in our population. It may be due to the
small sample size, genetic drift, or consanguineous marriages,
which are common in this region of the country.
In summary, our ﬁnding emphasizes the impact of CISH
polymorphisms on PTB protection in a sample of the Iranian
population. Further studies with larger sample sizes and dif-
ferent ethnicities are warranted to conﬁrm these ﬁndings. (100.0) – –
 (0.0) – –
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